Table 1.
Baseline characteristics of study participants
| Baseline characteristics | Values |
| Age, years | 50.17±9.37 |
| Male sex | 778 (69%) |
| Duration of diabetes, years | 9.13±6.56 |
| HbA1c, % | 6.70±1.23 |
| Uric acid, μmol/L | 388.43±96.21 |
| Total cholesterol, mmol/L | 5.22±1.71 |
| HDL-C, mmol/L | 1.13±0.39 |
| LDL-C, mmol/L | 3.11±1.35 |
| Triglyceride, mmol/L | 1.55 (1.11–2.14) |
| Systolic BP, mm Hg | 136.89±20.83 |
| Diastolic BP, mm Hg | 78.25±10.88 |
| Proteinuria, g/24 h | 1.59 (0.71–3.35) |
| Serum creatine, mg/dL | 1.29 (0.89–1.86) |
| eGFR (mL/min/1.73 m2) | 58.98 (38.36–92.03) |
| Follow-up, years | 3.26 (1.56–5.53) |
| Anemia, % | 49.91 |
| ASCVD, % | 16.9 |
Values for continuous variables given as mean±SD or median (IQR); for categorical variables, as count (percentage).
ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.